Profile
| Metric | Value |
|---|---|
| Full Name | Inspire Medical Systems, Inc. |
| Ticker | NYSE: INSP |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | inspiresleep.com |
| Employees | 1,246 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $94.10 | |
| Price, 1D Change | -4.36% | |
| Market Cap | $3B | |
| - | ||
| PE Ratio | 64.54 | |
| Beta | 1.15 | |
| Revenue | $803M | |
| Revenue, 1Y Change | +28.49% | |
| EPS | $1.75 | |
| EPS, 1Y Change | +342.68% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $1.75 | |
| EPS Estimate | $1.60 | |
| EPS Est. Change | -8.82% | |
| Revenue | $802.80M | |
| Revenue Estimate | $905.03M | |
| Revenue Est. Change | +12.73% | |
| Current Price | $94.10 | |
| Price Target | - | $130.00 |
| Price Tgt. Change | - | +38.16% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.14 | -$0.72 | +36.68% | |
| $1.33 | $1.75 | +31.45% | |
| $1.60 | N/A | -8.82% | |
| $1.68 | N/A | -4.37% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $619.52M | $624.80M | +0.85% | |
| $801.38M | $802.80M | +0.18% | |
| $905.03M | N/A | +12.73% | |
| $1.00B | N/A | +25.09% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -53.53% | |
| Price, 3Y | -61.32% | |
| Market Cap, 1Y | -54.60% | |
| Market Cap, 3Y | -61.25% | |
| Revenue, 1Y | +28.49% | |
| Revenue, 3Y | +243.97% | |
| EPS, 1Y | +342.68% | |
| EPS, 3Y | +213.60% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $94.10 | |
| SMA 200 | $114.05 | |
| SMA 200 vs Price | +21.21% | |
| SMA 50 | $102.82 | |
| SMA 50 vs Price | +9.27% | |
| Beta | 1.15 | |
| ATR | $6.19 | |
| 14-Day RSI | 45.25 | |
| 10-Day Volatility | 37.75% | |
| 1-Year Volatility | 71.07% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $802.80M | |
| EPS | $1.75 | |
| Gross Profit | $679.82M | |
| Gross Margin | 84.68% | |
| Operating Profit | $36.08M | |
| Operating Margin | 4.49% | |
| Net Income | $53.51M | |
| Net Margin | 6.67% | |
| EBITDA | $65.03M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.05 | |
| Current Ratio | 7.13 | |
| Quick Ratio | 6.22 | |
| Interest Coverage | 2,657.95 | |
| F-Score | 7 | |
| Altman Z-Score | 15.35 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 64.54 | |
| PS Ratio | 3.10 | |
| PB Ratio | 4.10 | |
| EV/EBITDA | 49.53 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $689.69M | |
| Cash & Equivalents | $445.55M | |
| Total Assets | $808.38M | |
| Current Assets | $630.81M | |
| Total Liabilities | $118.69M | |
| Current Liabilities | $88.50M | |
| Total Debt | $31.79M | |
| Short Term Debt | $1.75M | |
| Accounts Payable | $38.69M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $766.72M | |
| Operating Expenses | $643.74M | |
| Cost Of Goods Sold | $122.99M | |
| SG&A | $529.61M | |
| D&A | $6.55M | |
| Interest Expense | $22.00K | |
| Income Tax | $4.94M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $130.25M | |
| CFI | -$113.12M | |
| CFF | -$52.39M | |
| Capex | $39.12M | |
| Free Cash Flow | $91.12M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Truist Securities | → | |
| UBS | → | |
| RBC Capital | → | |
| Mizuho | → | |
| JP Morgan | → | |
| Piper Sandler | → | |
| Oppenheimer | → | |
| Baird | → | |
| Morgan Stanley | → | |
| Truist Securities | → |
Analyst sentiment
Institutional ownership
Screeners with INSP
Data Sources & References
- INSP Official Website www.inspiresleep.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1609550/000160955025000053/0001609550-25-000053-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1609550/000160955025000011/0001609550-25-000011-index.htm
- INSP Profile on Yahoo Finance finance.yahoo.com/quote/INSP
- INSP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/insp
FAQ
What is the ticker symbol for Inspire Medical Systems, Inc.?
The ticker symbol for Inspire Medical Systems, Inc. is NYSE:INSP
Does Inspire Medical Systems, Inc. pay dividends?
No, Inspire Medical Systems, Inc. does not pay dividends
What sector is Inspire Medical Systems, Inc. in?
Inspire Medical Systems, Inc. is in the Healthcare sector
What industry is Inspire Medical Systems, Inc. in?
Inspire Medical Systems, Inc. is in the Medical Devices industry
What country is Inspire Medical Systems, Inc. based in?
Inspire Medical Systems, Inc. is headquartered in United States
When did Inspire Medical Systems, Inc. go public?
Inspire Medical Systems, Inc. initial public offering (IPO) was on May 3, 2018
Is Inspire Medical Systems, Inc. in the S&P 500?
No, Inspire Medical Systems, Inc. is not included in the S&P 500 index
Is Inspire Medical Systems, Inc. in the NASDAQ 100?
No, Inspire Medical Systems, Inc. is not included in the NASDAQ 100 index
Is Inspire Medical Systems, Inc. in the Dow Jones?
No, Inspire Medical Systems, Inc. is not included in the Dow Jones index
When was Inspire Medical Systems, Inc. last earnings report?
Inspire Medical Systems, Inc.'s most recent earnings report was on November 3, 2025
When does Inspire Medical Systems, Inc. report earnings?
The next expected earnings date for Inspire Medical Systems, Inc. is February 11, 2026
